Spatial Transcriptomics

Spatial Transcriptomics is a molecular profiling method to determine the cellular localization of mRNA molecules on a tissue section. This was chosen as the method of the year by Nature magazine in 2020.
The Genomics Core Facility has established NanoString’s GeoMx Digital Spatial Profiler and the Visium Spatial 10x Genomics technologies.
The GeoMx DSP combines spatial and molecular profiling technologies by generating whole digital transcriptomes and profiling for 100s of validated proteins on FFPE or fresh frozen tissues, enabling to study biology in a spatial context. 
The Visium Spatial Gene Expression is a next-generation molecular profiling solution for classifying tissue based on total mRNA. This allows mapping the whole transcriptome with a morphological context in FFPE or fresh frozen tissues to discover novel insights into normal development and disease pathology. The GCF has the only Visium CytAssist instrument in Norway, which enables to profile pre-sectioned tissues using the Visium for FFPE and fresh frozen gene expression workflow.
The unique combination of high-plex and high-throughput spatial profiling of these technologies enables researchers to assess and quantify the biological implications of heterogeneity within tissue samples, and to study cellular microenvironments. For more information about applications of these technologies visit NanoString and 10x Genomics websites or contact us at 

Technology Overview

Visium Spatial 


Example from our services

GeoMx Spatial Transcriptomics of gastrointestinal stromal tumour (GIST). Morphology marker PanCK (green), CD45 (grey), SYTO13 (blue) & Vimentin (red).

Visium Spatial gastrointestinal stromal tumour. 



Aug 14, 2023

The Genomics and Bioinformatics Core Facilities resumes the drop-in hour every Wednesday between  2:30-3:30 PM. Follow the Zoom link below.

Jun 9, 2023

The Genomics Core Facility will not be accepting new sample submissions over the summer break. The deadline for submission is noon on Friday 7th of July. We will reopen again on Tuesday 1st of August. The sequencing of existing projects will continue, although turnaround times may be longer than usual.

We wish all our users a good summer

Contact Information:

Daily Leader Core Facility
Susanne Lorenz, PhD

Head of Core Facility
Leonardo A. Meza-Zepeda, Dr. philos.

Follow us via Twitter


Visiting address:

Genomics Core Facility (Room 3-F8-04)
Department of Core facilities
Institute for Cancer Research
New OCCI-building 
Norwegian Radium Hospital 
Ullernchaussen 66, Lamell 3, 2B 
NO-0379 Oslo, NORWAY

+47 - 9183 2772 Laboratory
+47 - 9183 3425 Office